US FDA expected to authorise Pfizer Covid vaccine for teens by next week

The US Food and Drug Administration is expected to authorise Pfizer's Covid-19 vaccine for those aged 12 years and above by next week.

The US Food and Drug Administration is expected to authorise Pfizer's Covid-19 vaccine for young adults age 12 and older by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year. Breaking News: The FDA is said to be preparing to expand use of Pfizer’s coronavirus vaccine to adolescents as young as 12 by next week, opening up the nation’s vaccination campaign to millions more Americans. https://t.co/3EFjeioXuB pic.twitter.com/JamMJuO6mo The announcement is set to come barely a month after the company found that its shot, which is already authorised for those age 16 and older, also provided protection for the younger group. The federal official, speaking on the condition of anonymity to preview the FDA's action, said the agency was expected to expand its emergency use authorisation for Pfizer's two-dose vaccine by early next week, and perhaps even sooner.